Impro Precision Industries (1286) H1 2024 earnings summary

Executive summary

• Revenue for 1H 2024 was HK$2,402.5 million, nearly flat year-over-year, with profit attributable to shareholders up 0.4% to HK$304.5 million and adjusted profit up 3.6% to HK$322.3 million.

• Gross profit increased 1.7% to HK$634.5 million, with gross margin rising to 26.4%.

• Interim dividend of HK$0.08 per share declared, unchanged from the prior year, with a 46.9% payout rate on adjusted profit.

• Resilient performance attributed to diversified end-markets and global footprint, offsetting sector weaknesses.

• Free cash inflow from operations dropped 43% to HK$156.6 million.

Financial highlights

• Adjusted EBITDA rose 5.4% to HK$694.3 million, with margin up to 28.9%.

• Adjusted profit attributable to shareholders was HK$322.3 million, up 3.6%.

• Adjusted basic EPS: 17.10 HK cents, up 3.6%.

• Cash and cash equivalents decreased 29.1% to HK$447.4 million; net debt increased 3.1% to HK$1,677.4 million.

• Market capitalization declined 13.3% to HK$3,925.6 million.

Outlook and guidance

• Full-year 2024 revenue growth forecast revised to 3–8%, reflecting macroeconomic and geopolitical risks.

• Strong demand for high horsepower engines and AI-driven data centers expected to continue.

• Medical segment's new products anticipated to enter mass production in late 2024 or 2025.

• Phase II of Mexico SLP campus to commence in H2 2024, expanding sand casting capacity.

• Ample liquidity with ~HK$1.95B undrawn banking facilities to support growth strategy.